Skip to main content
Premium Trial:

Request an Annual Quote

PathwayAssist 3.0, Causeway, Lasergene 6.0, FRED 2.0, Ensembl 26, BioCham 2.2, Pfam 16.0, E-Utilities


Ariadne Genomics has released PathwayAssist 3.0, which includes a database of more than 500,000 molecular interactions extracted from the literature using the company’s MedScan text processing tool.

QBioCom has launched version 1.2 of its Causeway sequence annotation software. The new release enables researchers to share annotations within an organization.

DNAStar has released Lasergene 6.0, an upgrade to its sequence analysis software that includes SeqBuilder, a new module for plasmid construction, as well as map creation capabilities and presentation-quality graphics, among other new features.

OpenEye Scientific Software has released FRED 2.0, a docking program that searches all possible poses within a protein active site, filtering for shape complementarity and optional features before being evaluated by several scoring functions.

Ensembl 26 is available at The release includes a new human assembly (NCBI build 35). Ensembl has also released preliminary assemblies for Xenopus tropicalis and Rattus norvegicus at

BioCham 2.2, an environment for modeling and simulating biochemical systems, is available at

Pfam 16.0 is available at and The latest collection of protein domain family alignments contains 7,677 families.

NCBI has released a new version of the SOAP interface for its E-Utilities at

Filed under

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more